Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,383.60
(
-1.42%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
106.54
(
2.27%
)
Bitcoin
80,485.64
(
-0.70%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 8998

Thursday, 05/24/2012 10:18:43 AM

Thursday, May 24, 2012 10:18:43 AM

Post# of 20689
Teva’s new CEO retained 2012 Copaxone guidance for worldwide sales of $3.8B (#msg-75927109); this suggests that my $2.6B forecast for 2012 US Copaxone sales in #msg-75407657 is reasonable and is close enough for modeling purposes.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote